Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women

Allergy and Asthma Proceedings

Volumn 34, Issue 2, 2013, Pages 162-169

  Baker, James W ^a   Craig, Timothy J ^b   Riedl, Marc A ^c   Banerji, Aleena ^d   Fitts, David ^e   Kalfus, Ira N ^f   Uknis, Marc E ^e  

^a Baker Allergy Asthma and Dermatology ^*  (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e ViroPharma Incorporated   (United States)

^f 6M2G Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; PLACEBO;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS OUTCOME; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; INFECTIOUS COMPLICATION; NAUSEA; OPEN STUDY; PREGNANCY OUTCOME; PREGNANT WOMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; RETROSPECTIVE STUDY; RHINOPHARYNGITIS; SINUSITIS; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VOMITING;

ADULT; ANGIOEDEMAS, HEREDITARY; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT INACTIVATING AGENTS; FEMALE; HUMANS; NANOTECHNOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 84876000160     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2013.34.3645     Document Type: Article

References (35)

1. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 6:24, 2010.
2. Davis AE III. The pathophysiology of hereditary angioedema. Clin Immunol 114:3-9, 2005.
3. Pappalardo E, Cicardi M, Duponchel C, et al. Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. J Allergy Clin Immunol 106:1147-1154, 2000. (Pubitemid 32006270)
4. Zuraw BL. Hereditary angioedema. N Engl J Med 359:1027-1036, 2008.
5. Banerji A. Hereditary angioedema: Classification, pathogenesis, and diagnosis. Allergy Asthma Proc 32:403-407, 2011.
6. Bernstein JA. Update on angioedema: Evaluation, diagnosis, and treatment. Allergy Asthma Proc 32:408-412, 2011.
7. Nzeako UC, Frigas E, and Tremaine WJ. Hereditary angioedema: A broad review for clinicians. Arch Intern Med 161: 2417-2429, 2001. (Pubitemid 33043115)
8. Bork K, Siedlecki K, Bosch S, et al. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 75:349-354, 2000. (Pubitemid 30187107)
9. Craig T, Riedl M, Dykewicz MS, et al. When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol 102:366-372, 2009.
10. Lumry WR, Castaldo AJ, Vernon MK, et al. The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc 31:407-414, 2010.
11. Frank MM. Hereditary angioedema: The clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 26:653-668, 2006. (Pubitemid 44666309)
12. Frank MM, Gelfand JA, and Atkinson JP. Hereditary angioedema: The clinical syndrome and its management. Ann Intern Med 84:580-593, 1976.
13. Gower RG, Busse PJ, Aygören-Pürsün E, et al. Hereditary angioedema caused by C1 esterase inhibitor deficiency: A literature-based analysis and clinical commentary on prophylaxis treatment strategies. WAO J 4(suppl):S9-S21, 2011.
14. Bork K, Meng G, Staubach P, and Hardt J. Hereditary angioedema: New findings concerning symptoms, affected organs, and course. Am J Med 119:267-274, 2006. (Pubitemid 43255068)
15. Bork K, Fischer B, and Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 114:294-298, 2003. (Pubitemid 36398075)
16. Bouillet L. Hereditary angioedema in women. Allergy Asthma Clin Immunol 6:17, 2010.
17. Bouillet L, Longhurst H, Boccon-Gibod I, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol 199:484.e1-484.e4, 2008.
18. Bouillet L, Ponard D, Drouet C, et al. Angioedema and oral contraception. Dermatology 206:106-109, 2003. (Pubitemid 36205275)
19. Visy B, Füst G, Varga L, et al. Sex hormones in hereditary angioneurotic oedema. Clin Endocrinol (Oxf) 60:508-515, 2004. (Pubitemid 38482515)
20. Chinniah N, and Katelaris CH. Hereditary angioedema and pregnancy. Aust N Z J Obstet Gynaecol 49:2-5, 2009.
21. Czaller I, Visy B, Csuka D, et al. The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: A long-term survey. Eur J Obstet Gynecol Reprod Biol 152:44-49, 2010.
22. Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, et al. Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. Am J Obstet Gynecol 203:131.e1-131.e7, 2010.
23. Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: Consensus document. Clin Exp Immunol 139:379-394, 2005. (Pubitemid 40333248)
24. Hermans C. Successful management with C1-inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: A case report. Arch Gynecol Obstet 276:271-276, 2007. (Pubitemid 47125082)
25. ViroPharma Biologics, Inc. Cinryze prescribing information. Exton, PA; 2011.
26. ViroPharma SPRL. Cinryze summary of product characteristics. Brussels, Belgium; 2011.
27. Baker JW, Sheffer A, Christensen J, et al. Cinryze replacement therapy in hereditary angioedema and pregnancy. J Allergy Clin Immunol 123(suppl 1):S106, 2009 (Abs).
28. Baker J, Riedl M, Banerji A, et al. Open-label use of nanofiltered C1 esterase inhibitor [human] [Cinryze] for treatment or prophylaxis of acute attacks of hereditary angioedema [HAE] in pregnant subjects. Ann Allergy Asthma Immunol 105:A10, 2010 (Abs).
29. Zuraw BL, Busse PJ, White M, et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 363:513-522, 2010.
30. Riedl MA, Hurewitz DS, Levy R, et al. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: An open-label trial. Ann Allergy Asthma Immunol 108:49-53, 2012.
31. Zuraw B, Baker J, Hurewitz D, et al. Open-label use of nanofiltered C1 esterase inhibitor [human] [Cinryze] for the prophylaxis of hereditary angioedema [HAE] attacks [poster #262]. Presented at the 2010 Annual Meeting of the American College of Allergy, Asthma and Immunology, Phoenix, AZ, November 11-16, 2010.
32. Bork K, Bygum A, and Hardt J. Benefits and risks of danazol in hereditary angioedema: A long-term survey of 118 patients. Ann Allergy Asthma Immunol 100:153-161, 2008. (Pubitemid 351238551)
33. Craig TJ. Appraisal of danazol prophylaxis for hereditary angioedema. Allergy Asthma Proc 29:225-231, 2008.
34. Ferring Pharmaceuticals, Inc. Lysteda prescribing information. Parsippany, NJ; 2010.
35. Craig TJ, Wasserman RL, Levy RJ, et al. Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema. J Clin Immunol 30:823-829, 2010.